Skip to content
HowShorted

HERON THERAPEUTICS, INC. short interest in 2019

In 2019, HERON THERAPEUTICS, INC.'s disclosed short interest ran from 16.99% of shares outstanding on 15 Jan 2019 to 20.65% on 31 Dec 2019, a change of +3.66 percentage points. The year's high was 23.97% on 15 Oct 2019 and its low 16.96% on 29 Mar 2019, averaging 20.22% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 32.39 days on 30 Aug 2019. Full history: HERON THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for HERON THERAPEUTICS, INC. in 2019

2019 in figures

Start of year
16.99% (15 Jan 2019)
End of year
20.65% (31 Dec 2019)
Change
+3.66 pp
High
23.97% (15 Oct 2019)
Low
16.96% (29 Mar 2019)
Average
20.22%
Highest days to cover
32.39 (30 Aug 2019)
SEC filings marked
9

Every report in 2019

HERON THERAPEUTICS, INC. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201916.99%12.99results (8-K)
31 Jan 201917.66%19.41
15 Feb 201917.84%19.73
28 Feb 201918.00%15.7810-K filed, results (8-K)
15 Mar 201918.00%13.12
29 Mar 201916.96%15.26
15 Apr 201917.62%16.55
30 Apr 201917.66%12.80
15 May 201918.75%5.5610-Q filed, results (8-K)
31 May 201917.74%15.74
14 Jun 201918.65%23.20
28 Jun 201921.67%20.03
15 Jul 201922.55%23.98
31 Jul 201923.08%27.10
15 Aug 201923.76%18.9110-Q filed, results (8-K)
30 Aug 201922.75%32.39
13 Sep 201923.44%23.44
30 Sep 201923.44%17.16
15 Oct 201923.97%10.94
31 Oct 201921.94%24.72
15 Nov 201921.46%18.1210-Q filed, results (8-K)
29 Nov 201920.50%20.90
13 Dec 201920.18%20.66
31 Dec 201920.65%17.99

See also: HERON THERAPEUTICS, INC.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.